» Articles » PMID: 18379567

The Cancer Stem Cell Hypothesis: in Search of Definitions, Markers, and Relevance

Overview
Journal Lab Invest
Specialty Pathology
Date 2008 Apr 2
PMID 18379567
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a disease of genes. Inherited or somatic alterations in genes are what make a normal cell ignore growth-controlling signals and form a tumor that eventually leads to the destruction of the organism. Based on accumulated knowledge on the genetic composition of cancer cells, the clonal evolution model of tumorigenesis was established, which explains multiple aspects of human disease and clinical observations. However, the recently popularized cancer stem cell hypothesis questions that all or most tumor cells can participate in tumor evolution and restricts this property to a subset of them defined as 'cancer stem cells' due to their stem cell-like characteristics. Enthusiasm surrounding this area of investigation and its presumed clinical implications led to a spurt of studies in various cancer types and model systems. Rigorous study design and critical data interpretation have to be employed to test the scientific and clinical relevance of the cancer stem cell hypothesis and its relationship to the clonal evolution model.

Citing Articles

ASXL1 truncating variants in BOS and myeloid leukemia drive shared disruption of Wnt-signaling pathways but have differential isoform usage of RUNX3.

Lin I, Awamleh Z, Sinvhal M, Wan A, Bondhus L, Wei A BMC Med Genomics. 2024; 17(1):282.

PMID: 39614348 PMC: 11606099. DOI: 10.1186/s12920-024-02039-7.


Meta-Analysis of Prognostic Significance of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.

Tripathi A, Singh M, Mishra P, Fatima N, Kumar V Asian Pac J Cancer Prev. 2024; 25(10):3597-3607.

PMID: 39471027 PMC: 11711375. DOI: 10.31557/APJCP.2024.25.10.3597.


Unraveling cancer progression pathways and phytochemical therapeutic strategies for its management.

Sharma V, Chaudhary A, Bawari S, Gupta S, Mishra R, Khan S Front Pharmacol. 2024; 15:1414790.

PMID: 39246660 PMC: 11377287. DOI: 10.3389/fphar.2024.1414790.


Cancer Stem Cells: Detection and Characterization from Solid Tumors.

Rehman A, Panda S, Tirino V, Del Vecchio V Methods Mol Biol. 2024; 2835:215-228.

PMID: 39105918 DOI: 10.1007/978-1-0716-3995-5_18.


Interactions between diet and gut microbiota in cancer.

Nakatsu G, Andreeva N, MacDonald M, Garrett W Nat Microbiol. 2024; 9(7):1644-1654.

PMID: 38907007 DOI: 10.1038/s41564-024-01736-4.


References
1.
Polyak K, Hahn W . Roots and stems: stem cells in cancer. Nat Med. 2006; 12(3):296-300. DOI: 10.1038/nm1379. View

2.
Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(7):3983-8. PMC: 153034. DOI: 10.1073/pnas.0530291100. View

3.
Ramirez-Castillejo C, Sanchez-Sanchez F, Andreu-Agullo C, Ferron S, Aroca-Aguilar J, Sanchez P . Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci. 2006; 9(3):331-9. DOI: 10.1038/nn1657. View

4.
Bonnet D, Dick J . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997; 3(7):730-7. DOI: 10.1038/nm0797-730. View

5.
Shipitsin M, Campbell L, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J . Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007; 11(3):259-73. DOI: 10.1016/j.ccr.2007.01.013. View